Metraipolis › archive › dc_98795fadddc3
Safety assessment of ustekinumab in inflammatory bowel disease: a real-world analysis based on the FDA adverse event reporting system (FAERS) — Europe PMC PMID:41390741
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41390741
- DOI
- 10.1186/s40001-[numero omesso]-z
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T16:20:21.219Z
- SHA-256 of the archived text
11150ed3e222ed27bf7620f9272cefa9f2cb06c1a0849c7972b80f3fcc0e44f3- Stable URL of this page
https://metraipolis.com/documento/dc_98795fadddc3
How to cite
Safety assessment of ustekinumab in inflammatory bowel disease: a real-world analysis based on the FDA adverse event reporting system (FAERS) — Europe PMC PMID:41390741 — Europe PMC (en), https://europepmc.org/article/MED/41390741 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_98795fadddc3 (Metraipolis archive dc_98795fadddc3, sha256 11150ed3e222ed27bf7620f9272cefa9f2cb06c1a0849c7972b80f3fcc0e44f3)
BibTeX
@misc{dc98795fadddc3,
title = {Safety assessment of ustekinumab in inflammatory bowel disease: a real-world analysis based on the FDA adverse event reporting system (FAERS) — Europe PMC PMID:41390741},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41390741},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_98795fadddc3; sha256 11150ed3e222ed27bf7620f9272cefa9f2cb06c1a0849c7972b80f3fcc0e44f3},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41390741. Agents can read the archived copy with the MCP tool read_document.